This study does not tell us what exactly causes long COVID or ME/CFS, nor does it test clinical symptoms like PEM.
But it may tell us something just as important - what type of biological problem this likely is..🧵
The authors isolated immunoglobulins (IgG) from people with post-infectious ME/CFS, including post-COVID ME/CFS, and tested what these antibodies do to healthy cells.
In a subset of patients, these IgG alter the behavior of endothelial cells and their mitochondria.
Not by killing the cells or shutting down ATP production.
Instead, mitochondria shift into a stress-adaptive state.
At rest, things may look relatively normal.
Under exertion, the system fails - post-exertional malaise (PEM).
A crucial detail.
The effect is Fab-dependent, not Fc-dependent.
That means antigen-specific binding, not random inflammation or generalized immune activation.
What does that imply?
The antibody is recognizing a specific structure (an antigen).
Importantly, the study did not find viral proteins in immune complexes.
So this is not evidence of ongoing viral infection.
Rather, it points to post-infectious immune memory that can persist independently.
That antigen does not need to be viral.
It may involve self-structures, such as
the extracellular matrix or endothelial regulatory components.
The result is not classic autoimmunity and not tissue destruction.
It looks more like a maintained stress-regulatory state, especially in the endothelium.
This helps explain why symptoms can remain relatively stable at rest,
yet collapse under exertion - because physiological reserves are already consumed.
A key implication.
Once a memory B-cell clone is established,
the original trigger is no longer required.
An acute infection may flip the system,
but the chronic condition is then maintained by immune memory and regulatory loops.
This may also explain why children and young people sometimes recover more easily.
Their immune system, endothelium, and tissues are more plastic
and better able to unlearn a maladaptive state.
In adults, the system is more stable.
Not because they are weaker,
but because adult biology is optimized for maintenance, not rewiring.
So this study does not point to a single culprit.
It points to a mechanism of disease persistence.
And that may be why simple fixes are so elusive - we are not trying to switch something off,
but to shift a biological system out of chronic threat mode.
Liu at al., Immunoglobulin G Complexes from Post-infectious ME/CFS, including post-COVID ME/CFS Disrupt Cellular Energetics and Alter Inflammatory Marker Secretion. sciencedirect.com/science/articl…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
If normal population plasma truly carries more low-grade inflammation, this study hints at a fork in the road.
Either we lower the bar and call it a new normal,
or this is a hidden population burden that will surface later as comorbidities🧵
A new study on the cytokine IL-32 after COVID-19 points directly at this uncomfortable question.
The authors analyzed nearly 1,000 healthy blood donors sampled before and during the pandemic, plus 212 hospitalized COVID-19 patients.
The result is consistent - plasma collected after 2020 shows systematically higher IL-32 levels compared to pre-pandemic plasma.
This isn’t a new comparison.
For years, parallels between NeuroHIV and neuro-COVID/Long COVID have been discussed across fields.
What’s new is that they are now formally described as shared CNS mechanisms, not just analogy!🧵
Just a few years ago, parallels like
HIV - SARS-CoV-2
HAND - brain fog/neuro-LC
microglia - chronic inflammation
vasculature - cognition
were treated mainly as interesting analogies. With caution not to overstate them.
This new review formalizes the shift. These parallels are not Twitter pattern recognition, but convergent CNS phenotypes following viral insults.
A new review shows they are biologically grounded similarities.
A new review links Alzheimer’s disease, Parkinson’s disease, and COVID-19 through a shared core - neuroinflammation + oxidative stress.
The same pathways, the same immune nodes, the same vulnerabilities of the brain🧵
Key players.
Microglia (the brain’s innate immune cells) and neutrophils (peripheral rapid responders).
When the blood–brain barrier (BBB) is disrupted, neutrophils enter the CNS and inflammation becomes self-amplifying.
Neutrophils can form NETs (neutrophil extracellular traps - DNA + histones + enzymes like MPO/elastase).
In the brain, NETs mean oxidative damage, mitochondrial stress, neuronal injury - and further microglial activation. A vicious cycle.
Long COVID in children is often reduced to fatigue.
This study shows something far more concrete - measurable impairment in language skills - speaking, listening, and reading🧵
A new single-cell multiome study helps answer a key long-COVID question.
Where do the pathological monocyte programs seen later actually come from?
This paper maps how classical monocytes change already during the acute phase of COVID-19.
Using paired RNA + chromatin profiling, the authors analyze immune cells across disease severity from healthy controls to critical COVID.
A clear pattern emerges -
myeloid cells, especially classical monocytes, carry much of the severity-associated signal.
The choroid plexus (ChP) has become one of the most consistent findings in post-COVID and long COVID neuroimaging.
It is enlarged.
But larger alone doesn’t yet tell us what is actually happening🧵
A new paper in Alzheimer’s & Dementia moves the ChP story one step further.
It’s no longer just about volume - the authors also measure choroid plexus blood flow (CBF) and link it to cognition and biomarkers.
Study design.
86 long COVID patients, 67 recovered COVID, 26 healthy controls.
MRI + pCASL perfusion imaging.
In a subset of long COVID patients, blood biomarkers (GFAP, p-tau217, etc)